Kits Eyecare (TSE:KITS – Get Free Report) had its price target lowered by equities researchers at Canaccord Genuity Group from C$23.00 to C$22.00 in a research note issued to investors on Thursday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s target price indicates a potential upside of 92.48% from the stock’s previous close.
Several other analysts have also recently weighed in on the company. ATB Cormark Capital Markets lowered their price target on Kits Eyecare from C$20.00 to C$16.75 and set a “speculative buy” rating on the stock in a report on Thursday. Stifel Nicolaus decreased their price objective on shares of Kits Eyecare from C$24.00 to C$21.00 and set a “buy” rating on the stock in a research report on Thursday. Finally, Desjardins lowered their target price on shares of Kits Eyecare from C$25.00 to C$23.00 and set a “buy” rating on the stock in a research note on Thursday. Four research analysts have rated the stock with a Buy rating, According to MarketBeat, Kits Eyecare has a consensus rating of “Buy” and an average target price of C$20.69.
Check Out Our Latest Research Report on KITS
Kits Eyecare Price Performance
Kits Eyecare (TSE:KITS – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported C$0.06 earnings per share (EPS) for the quarter. The business had revenue of C$57.47 million during the quarter.
About Kits Eyecare
KITS (TSX: KITS) is one of the world’s fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.
Further Reading
Receive News & Ratings for Kits Eyecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kits Eyecare and related companies with MarketBeat.com's FREE daily email newsletter.
